ALPS

Alps Group Inc

Healthcare · $67M market cap

Verdict

We can't put a fair value on ALPS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth15.2% a year✓
Free cash flow growth—?
Return on invested capital-13.9%✗

Follow ALPS

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Alps Group Inc

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

ALPS stock (Alps Group Inc): ownership and insider trades — PaybackPrice